Thomas G. Evans

8.9k total citations
133 papers, 4.9k citations indexed

About

Thomas G. Evans is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Thomas G. Evans has authored 133 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Epidemiology, 45 papers in Immunology and 33 papers in Infectious Diseases. Recurrent topics in Thomas G. Evans's work include HIV Research and Treatment (23 papers), Immunotherapy and Immune Responses (22 papers) and Tuberculosis Research and Epidemiology (16 papers). Thomas G. Evans is often cited by papers focused on HIV Research and Treatment (23 papers), Immunotherapy and Immune Responses (22 papers) and Tuberculosis Research and Epidemiology (16 papers). Thomas G. Evans collaborates with scholars based in United States, United Kingdom and New Zealand. Thomas G. Evans's co-authors include Richard D. Pearson, John B. Hibbs, David C. Montefiori, Maria Jânia Teixeira, Spotswood L. Spruance, A. W. Vasconcelos, José Wellington de Oliveira Lima, Anastácio de Queiroz Sousa, Michael C. Keefer and L. Thai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Thomas G. Evans

133 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas G. Evans United States 44 2.0k 1.6k 1.3k 1.1k 958 133 4.9k
Robert F. Garry United States 43 1.9k 0.9× 1.3k 0.8× 3.2k 2.4× 1.0k 1.0× 1.6k 1.7× 227 7.1k
Wendy Maury United States 35 1.1k 0.5× 1.3k 0.8× 2.2k 1.7× 1.3k 1.2× 1.0k 1.1× 96 4.5k
Michael D. George United States 27 1.5k 0.7× 1.2k 0.7× 843 0.6× 887 0.8× 1.6k 1.7× 41 4.6k
Thomas N. Denny United States 42 916 0.5× 1.5k 0.9× 1.2k 0.9× 1.4k 1.3× 1.1k 1.2× 162 5.0k
Daniel M. Altmann United Kingdom 43 1.6k 0.8× 3.8k 2.3× 2.2k 1.6× 1.9k 1.8× 1.8k 1.8× 162 9.2k
Trine H. Mogensen Denmark 36 1.9k 0.9× 3.9k 2.3× 1.3k 0.9× 465 0.4× 2.1k 2.2× 116 7.0k
Dana G. Wolf Israel 42 3.4k 1.7× 1.5k 0.9× 1.9k 1.4× 303 0.3× 961 1.0× 159 6.6k
Satya Dandekar United States 52 1.7k 0.8× 2.8k 1.7× 2.2k 1.6× 3.6k 3.4× 1.9k 2.0× 157 8.1k
Cornelia L. Dekker United States 46 3.7k 1.8× 4.2k 2.6× 1.5k 1.1× 424 0.4× 1.8k 1.9× 104 8.5k
Christian Devaux France 44 666 0.3× 2.4k 1.4× 2.7k 2.0× 1.2k 1.1× 1.5k 1.6× 184 7.4k

Countries citing papers authored by Thomas G. Evans

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Evans more than expected).

Fields of papers citing papers by Thomas G. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Evans. The network helps show where Thomas G. Evans may publish in the future.

Co-authorship network of co-authors of Thomas G. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Evans. A scholar is included among the top collaborators of Thomas G. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Evans. Thomas G. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tak, Won Young, Wan‐Long Chuang, Chi-Yi Chen, et al.. (2024). Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB. Journal of Hepatology. 81(6). 949–959. 17 indexed citations
2.
Cargill, Tamsin, Paola Cicconi, Anthony Brown, et al.. (2023). HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV. JHEP Reports. 5(11). 100885–100885. 9 indexed citations
3.
Smith, Neal P., et al.. (2022). Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling. Vaccine. 40(49). 7032–7041. 6 indexed citations
4.
Darrah, Patricia A., Robert M. DiFazio, Pauline Maiello, et al.. (2019). Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques. npj Vaccines. 4(1). 21–21. 42 indexed citations
5.
Berg, Robert A. van den, Laurane De Mot, Geert Leroux‐Roels, et al.. (2018). Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults. Frontiers in Immunology. 9. 564–564. 28 indexed citations
6.
Long, Jennifer, et al.. (2017). Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK. The Breast Journal. 24(4). 580–585. 15 indexed citations
7.
Smith, Clare M., Megan K. Proulx, Andrew J. Olive, et al.. (2016). Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype. mBio. 7(5). 131 indexed citations
8.
Kling, Heather M., Gerard J. Nau, Ted M. Ross, et al.. (2014). Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy. Annals of the American Thoracic Society. 11(Supplement_4). S201–S210. 6 indexed citations
9.
Evans, Thomas G., Michael J. Brennan, Lew Barker, & Jelle Thole. (2013). Preventive vaccines for tuberculosis. Vaccine. 31. B223–B226. 25 indexed citations
10.
Keitel, Wendy A., John J. Treanor, Hana M. El Sahly, et al.. (2009). Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults. Human Vaccines. 5(8). 536–544. 19 indexed citations
11.
Goepfert, Paul A., Georgia D. Tomaras, Helen Horton, et al.. (2006). Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine. 25(3). 510–518. 71 indexed citations
12.
Rompay, Koen K. A. Van, Kristina Abel, Raman P. Singh, et al.. (2005). Attenuated Poxvirus-Based Simian Immunodeficiency Virus (SIV) Vaccines Given in Infancy Partially Protect Infant and Juvenile Macaques Against Repeated Oral Challenge With Virulent SIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(2). 124–134. 81 indexed citations
13.
Bruyn, Guy de, Anthony Rossini, Ya-Lin Chiu, et al.. (2003). Safety profile of recombinant canarypox HIV vaccines. Vaccine. 22(5-6). 704–713. 53 indexed citations
14.
Vedhara, Kavita, Michael McDermott, Thomas G. Evans, et al.. (2002). Chronic stress in nonelderly caregivers. Journal of Psychosomatic Research. 53(6). 1153–1161. 68 indexed citations
15.
Evans, Thomas G., M. Juliana McElrath, Thomas J. Matthews, et al.. (2001). QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans. Vaccine. 19(15-16). 2080–2091. 106 indexed citations
16.
Jerônimo, Selma M. B., et al.. (2000). Natural History of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: Long-Term Follow-Up. Clinical Infectious Diseases. 30(3). 608–609. 72 indexed citations
17.
Hasan, Muhammad, et al.. (1999). Granulocyte Macrophage Colony–Stimulating Factor as an Adjuvant for Hepatitis B Vaccination of Healthy Adults. The Journal of Infectious Diseases. 180(6). 2023–2026. 28 indexed citations
18.
Spruance, Spotswood L., Thomas G. Evans, Mark B. McKeough, et al.. (1995). Th1Th2-like immunity and resistance to herpes simplex labialis. Antiviral Research. 28(1). 39–55. 36 indexed citations
19.
Geddes, D M, et al.. (1991). Unstable asthma and theophylline.. BMJ. 303(6813). 1317–1319. 2 indexed citations
20.
Evans, Thomas G.. (1968). A grammar-controlled pattern analyzer.. IFIP Congress. 1592–1598. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert F. Garry Breakdown of academic impact, for papers by Wendy Maury Breakdown of academic impact, for papers by Michael D. George Breakdown of academic impact, for papers by Thomas N. Denny Breakdown of academic impact, for papers by Daniel M. Altmann Breakdown of academic impact, for papers by Trine H. Mogensen Breakdown of academic impact, for papers by Dana G. Wolf Breakdown of academic impact, for papers by Satya Dandekar Breakdown of academic impact, for papers by Cornelia L. Dekker Breakdown of academic impact, for papers by Christian Devaux
Rankless by CCL
2026